Durvalumab and Tremelimumab for Pediatric Malignancies
AstraZeneca
AstraZeneca
National Cancer Institute (NCI)
AstraZeneca
Cedars-Sinai Medical Center
AstraZeneca
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Eli Lilly and Company
Roswell Park Cancer Institute
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
H. Lee Moffitt Cancer Center and Research Institute
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Canadian Cancer Trials Group
Acerta Pharma BV
Dana-Farber Cancer Institute
Celgene
Pfizer
MedImmune LLC
AstraZeneca
National Cancer Institute (NCI)
MedImmune LLC
University of Virginia
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Celgene
Providence Health & Services
Dana-Farber Cancer Institute
University of Pittsburgh
Acerta Pharma BV
Transgene
AstraZeneca
University of California, Davis
Dizal Pharmaceuticals
University of Iowa
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Brigham and Women's Hospital
Incyte Corporation
Eli Lilly and Company